Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2906 results found
2025 ∙ Elghanam, Y. Kim, E. Y.
Impact of pharmacist intervention on enhancing vaccination coverage: A systematic review and meta-analysis
Adults Older adults Parents/caregivers Coverage
Rating:
Not applicable
2025 ∙ Amare, S. N. Yee, K. C. Leung, M. Naunton, M. Bushell, M.
Impact of pharmacist-led interventions on COVID-19, herpes zoster, influenza, pneumococcal, and respiratory syncytial virus vaccines uptake in people aged 60 years and older: Systematic review and meta-analysis
Adults Older adults Herpes zoster Influenza Pneumococcal disease RSV (Respiratory syncytial virus) COVID-19 Coverage
Rating:
Not applicable
2025 ∙ Pan, B. Y. Tseng, I. S. Feng, Y. C. Fang, C. T.
Impact of pre-Omicron COVID-19 vaccine boosters on the risk of Omicron variant infections: A systematic review and meta-regression
All age groups COVID-19 Efficacy/effectiveness Administration
Rating:
Low
2025 ∙ Saikia, K. Ahmed, R. Das, B. Paul, S. Ray, S. K. Chandra Deka, R. Borah, P. P. Saharia, N. Namsa, N. D.
Impact of Rotavac Vaccine on Hospital-Based Disease Prevalence and Strain Diversity in India: A Systematic Review and Meta-Analysis
South-East Asia India Newborn Children Rotavirus Efficacy/effectiveness
Rating:
Low
2025 ∙ Wang, C. Peng, L. Huang, X. Tsang, T. K.
Impact of Vaccination and Public Health Measures on the Severity of SARS-CoV-2 Omicron Infections in China: A Systematic Review and Meta-Regression Analysis
Western Pacific China All age groups COVID-19 Efficacy/effectiveness Administration
Rating:
Critically low
2025 ∙ Ong, D. S. Harris, M. Hart, J. D. Russell, F. M.
Indirect Effects of Universal Infant Rotavirus Vaccination: A Narrative Systematic Review
All age groups Low and Middle Income Countries Rotavirus Efficacy/effectiveness
Rating:
Moderate
2025 ∙ Yang, W. K. Shao, S. C. Liu, C. C. Chi, C. C.
Influenza vaccination and risk of dementia: a systematic review and meta-analysis
All age groups Influenza Efficacy/effectiveness Administration
Rating:
Low
2025 ∙ Thomas, R. E. Jefferson, T. Lasserson, T. J. Earnshaw, S.
Influenza vaccination for healthcare workers who care for people aged 60 or older living in long‐term care institutions
Healthcare workers Influenza Efficacy/effectiveness
Rating:
High
2025 ∙ Presa, J. Arranz-Herrero, J. Alvarez-Losa, L. Rius-Rocabert, S. Pozuelo, M. J. Lalueza, A. Ochando, J. Eiros, J. M. Sanz-Munoz, I. Nistal-Villan, E.
Influenza vaccine outcomes: a meta-analysis revealing morbidity benefits amid low infection prevention
All age groups Influenza Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Wheeler, S. G. Beste, L. A. Overland, M. K. Wander, P. L.
Interventions in primary care to increase uptake of adult vaccines: a systematic review
Adults Older adults Coverage
Rating:
Not applicable
Loading...